These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8944372)

  • 1. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?
    Seibold F; Weber P; Schöning A; Mörk H; Goppel S; Scheurlen M
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1095-100. PubMed ID: 8944372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
    Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
    Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
    Vidrich A; Lee J; James E; Cobb L; Targan S
    J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
    Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
    Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
    Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
    J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis.
    Pokorny CS; Norton ID; McCaughan GW; Selby WS
    J Gastroenterol Hepatol; 1994; 9(1):40-4. PubMed ID: 8155865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study.
    Ooi CJ; Lim BL; Cheong WK; Ling AE; Ng HS
    Ann Acad Med Singap; 2000 Nov; 29(6):704-7. PubMed ID: 11269973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
    Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
    Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
    Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
    Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
    Bansi DS; Fleming KA; Chapman RW
    Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
    Bansi D; Chapman R; Fleming K
    J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
    Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
    Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease.
    Müller-Ladner U; Gross V; Andus T; Gschwendtner H; Roth M; Caesar I; Schölmerich J; Lang B
    Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):579-84. PubMed ID: 8823574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.